Evidence map›Paper›PMID 33984364›Full record

ArticleJournal of molecular biology2021

Cancer-Associated Mutations Perturb the Disordered Ensemble and Interactions of the Intrinsically Disordered p53 Transactivation Domain.

Lynn G Schrag, Xiaorong Liu, Indhujah Thevarajan, Om Prakash, Michal Zolkiewski, Jianhan Chen

Open access · greenAbstract read
In one paragraph

Article in Journal of molecular biology, 2021. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
1.7field-weighted citation impact, top 13% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 25 citations in OpenAlex.

  1. Article
  2. Review
  3. Article
  4. Article
  5. Review
  6. Article
  7. Article
  8. Structural biases in disordered proteins are prevalent in the cell.Nature structural & molecular biology · 2024
    Article
  9. Review
  10. Review
  11. Review
  12. Review
  13. Article
  14. Article
  15. Review
  16. Review
  17. Matrin3: Disorder and ALS Pathogenesis.Frontiers in molecular biosciences · 2021
    Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

6 authors at 2 institutions in 1 country.

Lynn G SchragDepartment of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, KS 66505, USA.
Xiaorong LiuDepartment of Chemistry, University of Massachusetts Amherst, Amherst, MA 01003, USA.
Indhujah ThevarajanDepartment of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, KS 66505, USA.
Om PrakashDepartment of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, KS 66505, USA. Electronic address: omp@ksu.edu.
Michal ZolkiewskiDepartment of Biochemistry and Molecular Biophysics, Kansas State University, Manhattan, KS 66505, USA. Electronic address: michalz@ksu.edu.
Jianhan ChenDepartment of Chemistry, University of Massachusetts Amherst, Amherst, MA 01003, USA; Department of Biochemistry and Molecular Biology, University of Massachusetts Amherst, Amherst, MA 01003, USA. Electronic address: jianhanc@umass.edu.
Kansas State University · USUniversity of Massachusetts Amherst · US

Funding

Multi-scale enhanced sampling of disordered proteins: Admin Supplement InstrumentationR01GM114300 · NIGMS · UNIVERSITY OF MASSACHUSETTS AMHERST · PI CHEN, JIANHAN · 2016 to 2020
$1.5M
NIGMS NIH HHS R01 GM114300
6 · The paper itself

Abstract

Intrinsically disordered proteins (IDPs) are key components of regulatory networks that control crucial aspects of cell decision making. The intrinsically disordered transactivation domain (TAD) of tumor suppressor p53 mediates its interactions with multiple regulatory pathways to control the p53 homeostasis during the cellular response to genotoxic stress. Many cancer-associated mutations have been discovered in p53-TAD, but their structural and functional consequences are poorly understood. Here, by combining atomistic simulations, NMR spectroscopy, and binding assays, we demonstrate that cancer-associated mutations can significantly perturb the balance of p53 interactions with key activation and degradation regulators. Importantly, the four mutations studied in this work do not all directly disrupt the known interaction interfaces. Instead, at least three of these mutations likely modulate the disordered state of p53-TAD to perturb its interactions with regulators. Specifically, NMR and simulation analysis together suggest that these mutations can modulate the level of conformational expansion as well as rigidity of the disordered state. Our work suggests that the disordered conformational ensemble of p53-TAD can serve as a central conduit in regulating the response to various cellular stimuli at the protein-protein interaction level. Understanding how the disordered state of IDPs may be modulated by regulatory signals and/or disease associated perturbations will be essential in the studies on the role of IDPs in biology and diseases.

Indexed as

MutationBinding SitesHumansMagnetic Resonance SpectroscopyModels, MolecularMolecular Dynamics SimulationNeoplasmsProtein BindingProtein ConformationProtein DomainsProtein Interaction MapsTranscriptional ActivationTumor Suppressor Protein p53TP53 protein, humanTumor Suppressor Protein p53atomistic simulationbiolayer interferometryconformational equilibriumintrinsically disordered proteinsNMR

Identifiers

PMID33984364
PMCPMC8286338
OpenAlexW3163638763

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.